SCHEMBL31129141

SCHEMBL31129141

CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN)C(C)C)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)O)[C@@H](C)CC)C(C)C

nearest known ligand 0.60

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
▸ C5AR1 P21730 1/20 0.59
▸ OPRD1 P41143 5/20 0.58
▸ EPHA2 P29317 2/20 0.54
▸ NTSR1 P30989 2/20 0.54
▸ NPY1R P25929 1/20 0.54
▸ NPY2R P49146 1/20 0.54
▸ NPY4R P50391 1/20 0.54
▸ NPY5R Q15761 1/20 0.54
▸ OPRM1 P35372 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31129138 0.98 OPRD1 (0.61) C5AR1OPRD1EPHA2NTSR1NPY1R
SCHEMBL30872254 0.97 C5AR1 (0.58) C5AR1OPRD1EPHA2NPY1RNPY2R
SCHEMBL31129133 0.97 OPRD1 (0.62) C5AR1OPRD1EPHA2NTSR1OPRM1
SCHEMBL31129136 0.96 OPRD1 (0.56) C5AR1OPRD1EPHA2NTSR1NPY1R
SCHEMBL31129150 0.96 OPRD1 (0.59) C5AR1OPRD1EPHA2NPY1RNPY2R
SCHEMBL31129143 0.95 OPRD1 (0.57) C5AR1OPRD1NPY1RNPY2RNPY4R
SCHEMBL31129142 0.93 OPRD1 (0.57) OPRD1NTSR1NPY1RNPY2RNPY4R
SCHEMBL31633302 0.93 NPY2R (0.63) OPRD1NPY1RNPY2RNPY4RNPY5R
SCHEMBL30105815 0.93 NPY2R (0.63) OPRD1NPY1RNPY2RNPY4RNPY5R
SCHEMBL31129135 0.92 NPY2R (0.60) OPRD1NPY1RNPY2RNPY4RNPY5R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118745209-A Stable antibacterial peptide in blood plasma and preparation method and application thereof 国家纳米科学中心 2024-10-08 — — CN disclosed
Send feedback